Skip to main content
Premium Trial:

Request an Annual Quote

Strategic Diagnostics Expands Maine Facility, Boosts Antibody Production by Half

NEW YORK (GenomeWeb News) - Strategic Diagnostics has expanded its antibody-production facility in Windham, Maine, the company said Tuesday.
 
The Newark, Del.-based company said the newly added 15,000-square-foot space, which will begin operating in mid-November, will allow it to boost polyclonal antibody production by 44 percent.
 
Strategic Diagnostics said the extra capacity will enable it to meet “surging” demand for its Genomic Antibody Technology platform and to support the recent launch of its web-based catalog of oncology-focused antibody reagents.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.